<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>31(6)</volume><submitter>Castro-Oropeza R</submitter><pubmed_abstract>Long non‑coding RNAs (lncRNAs) are key regulators of gene expression, that can regulate a range of carcinogenic processes. Moreover, they exhibit stability in biological fluids, with some displaying tissue specificity. As their expression depends on specific conditions or is linked to the regulation of particular signaling pathways, lncRNAs are promising candidates for providing insights into the likely progression of the disease. This allows for the stratification of patients based on their risk of progression, making them potential prognostic biomarkers in various types of cancer. In addition, the tissue‑specific expression profile of lncRNAs renders them ideal candidates for detection, prognosis and monitoring of cancer progression. The present study aims to provide an overview of diffe</pubmed_abstract><journal>Molecular medicine reports</journal><pagination>163</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12015155</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Landscape of lncRNAs expressed in Mexican patients with triple‑negative breast cancer.</pubmed_title><pmcid>PMC12015155</pmcid><pubmed_authors>Mantilla-Morales A</pubmed_authors><pubmed_authors>Rios-Sarabia N</pubmed_authors><pubmed_authors>Ruiz Tachiquin ME</pubmed_authors><pubmed_authors>Pina-Sanchez P</pubmed_authors><pubmed_authors>Castro-Oropeza R</pubmed_authors><pubmed_authors>Mayani H</pubmed_authors><pubmed_authors>Torres J</pubmed_authors><pubmed_authors>Vazquez-Santillan K</pubmed_authors><pubmed_authors>Velazquez-Velazquez C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Landscape of lncRNAs expressed in Mexican patients with triple‑negative breast cancer.</name><description>Long non‑coding RNAs (lncRNAs) are key regulators of gene expression, that can regulate a range of carcinogenic processes. Moreover, they exhibit stability in biological fluids, with some displaying tissue specificity. As their expression depends on specific conditions or is linked to the regulation of particular signaling pathways, lncRNAs are promising candidates for providing insights into the likely progression of the disease. This allows for the stratification of patients based on their risk of progression, making them potential prognostic biomarkers in various types of cancer. In addition, the tissue‑specific expression profile of lncRNAs renders them ideal candidates for detection, prognosis and monitoring of cancer progression. The present study aims to provide an overview of diffe</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2026-06-01T12:53:09.535Z</modification><creation>2025-07-03T03:04:59.014Z</creation></dates><accession>S-EPMC12015155</accession><cross_references><pubmed>40211710</pubmed><doi>10.3892/mmr.2025.13528</doi></cross_references></HashMap>